Skip to main content
. 2017 Nov;72(11):675–680. doi: 10.6061/clinics/2017(11)05

Table 3.

Risk factors (prevalence odds ratio, 95% CI) associated with patient death by univariate and multivariate analyses (Cox regression).

Risk factors, N (%) Univariate analysis Multivariate analysis Multivariate analysis p value
Age > 62 years 1.1 (0.9 – 1.3) not included
Gender Male 1.1 (0.9 – 1.4) not included
Histology type of primary tumor
Adenocarcinoma Comparator
Large cell carcinoma 1.3 (0.8 – 2.2)
Squamous cell carcinoma 1.3 (1.0 – 1.6)
Small cell lung cancer 2.3 (1.7 – 3.2)* 2.0 (1.5 – 2.8) <0.001
Stages of cancer
Ia/Ib comparator
IIa/IIb 1.6 (0.8 – 3.2) 2.5 (1.4 – 4.6) 0.002
IIIa/IIIb 2.7 (1.6 – 4.7)* 3.0 (1.7 – 5.4) <0.001
IV 3.7 (2.2 – 6.2)* - ns
Extensive 3.9 (2.2 – 6.9)* - ns
Limited 2.7 (1.3 – 5.6)* - ns
No surgical treatment for lung cancer comparator
Surgical treatment for lung cancer 0.4 (0.3 – 0.6)* 0.6 (0.4 – 0.9) 0.005
Time from PH to DX > 3 months 1.0 (0.8 – 1.2) not included
Time from first app to DX > 2 months 1.2 (1.0 – 1.5) not included
Time from DX to TTO < 1.5 months 1.8 (1.4 – 2.2)* 2.1 (1.6 – 2.6) <0.001
*

p value <0.05 (univariate analysis by Cox regression).